Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125596391 | 12559639 | 1 | I | 20160712 | 20160715 | 20160715 | EXP | CA-AMGEN-CANSP2016091152 | AMGEN | 39.00 | YR | A | M | Y | 0.00000 | 20160715 | OT | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125596391 | 12559639 | 1 | PS | ENBREL | ETANERCEPT | 1 | Unknown | 50 MG, QWK | U | 103795 | 50 | MG | UNKNOWN FORMULATION | /wk | |||||
| 125596391 | 12559639 | 2 | SS | METHOTREXATE. | METHOTREXATE | 1 | Subcutaneous | 25 MG, UNK | 0 | 25 | MG | ||||||||
| 125596391 | 12559639 | 3 | SS | METHOTREXATE. | METHOTREXATE | 1 | Subcutaneous | 12.5 MG, QWK | 0 | 12.5 | MG | /wk | |||||||
| 125596391 | 12559639 | 4 | SS | SULFASALAZINE. | SULFASALAZINE | 1 | Oral | 500 MG, UNK | 0 | 500 | MG | ||||||||
| 125596391 | 12559639 | 5 | C | ESOMEPRAZOLE | ESOMEPRAZOLE | 1 | UNK | 0 | |||||||||||
| 125596391 | 12559639 | 6 | C | FOLIC ACID. | FOLIC ACID | 1 | UNK | 0 | |||||||||||
| 125596391 | 12559639 | 7 | C | HYDROXYCHLOROQUINE | HYDROXYCHLOROQUINE | 1 | UNK | 0 | |||||||||||
| 125596391 | 12559639 | 8 | C | LEFLUNOMIDE. | LEFLUNOMIDE | 1 | 20 MG, UNK | 0 | 20 | MG | TABLET | ||||||||
| 125596391 | 12559639 | 9 | C | NAPROXEN SODIUM. | NAPROXEN SODIUM | 1 | UNK | 0 | |||||||||||
| 125596391 | 12559639 | 10 | C | PREDNISONE. | PREDNISONE | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125596391 | 12559639 | 1 | Rheumatoid arthritis |
| 125596391 | 12559639 | 2 | Product used for unknown indication |
| 125596391 | 12559639 | 4 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125596391 | 12559639 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125596391 | 12559639 | Arthralgia | |
| 125596391 | 12559639 | Back pain | |
| 125596391 | 12559639 | C-reactive protein abnormal | |
| 125596391 | 12559639 | Condition aggravated | |
| 125596391 | 12559639 | Crepitations | |
| 125596391 | 12559639 | Dermatitis allergic | |
| 125596391 | 12559639 | Drug dose omission | |
| 125596391 | 12559639 | Fatigue | |
| 125596391 | 12559639 | Hepatic steatosis | |
| 125596391 | 12559639 | Joint injury | |
| 125596391 | 12559639 | Joint swelling | |
| 125596391 | 12559639 | Lymphadenopathy | |
| 125596391 | 12559639 | Musculoskeletal pain | |
| 125596391 | 12559639 | Musculoskeletal stiffness | |
| 125596391 | 12559639 | Pain | |
| 125596391 | 12559639 | Pain in extremity | |
| 125596391 | 12559639 | Pleuritic pain | |
| 125596391 | 12559639 | Red blood cell sedimentation rate abnormal | |
| 125596391 | 12559639 | Rheumatoid arthritis | |
| 125596391 | 12559639 | Rheumatoid nodule | |
| 125596391 | 12559639 | Transaminases increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |